International Congress on Coronaviruses™ (ICCovid™)


ICCovid 2022™ will be held on May 18-120, 2022 in San Francisco. ICCovid 2022 is a leading forum in research and drug developmen for the prevention and treatment of Covid-19. The Congress will highlight the latest accomplishments in Covid-19 research and best practice in patient care.

The theme of the 2022 Congress is “United Front Against Covid-19”.

ICCovid 2022 encourages new concepts and hypotheses on the etiology and potential prevention or treatment therapy, and best practice in Covid-19 patient care.

General guidelines for preparing an abstract to ICCovid 2022

Your abstract should fit into one page of standard letter size (US letter size, 8½ inches wide and 11 inches long), using font ARIAL size 12, with a layout margin of 1 inch left and right, and 1 inch top and bottom. Approximately 460-480 words of font Arial size 12 fit in to one letter size page. A scientific abstract normally consists of the following headers with suggested number of words to fit into one leter size page with some flexibility.

1. Title of the abstract: Keep in Concise, Capitalize Each Word: about 20 words

2. Authors and Organization: about 20 words

3. Background: about 100 words

4. Methods: A brief description of the experimental method- about 160 words.

5. Results: A brief description of results, about 150 words

6. Conclusion: about 30 words

Submit your abstract

Submit your Abstract

Submit your abstract today.

The deadline of abstract submission is September 30, 2021.

The deadline for late breaking news of clinical trial reports to the Congress is October 31, 2021

PRESENTATION TYPES


Authors may apply for an oral presentation or a poster presentation when submitting an abstract to the International Congress on Covid. Decision will made by the Program Committee basedon the merit of the abstracts and the availability of speaking schedules.

ICCovid ORAL PRESENTATION

  • Oral presentation is 20 minutes including questions and answers.
  • Accepted oral presentations will be scheduled for May 18-20, 2022.
  • A person can be the presenting author for an oral presentation and a poster presentation .
  • Submitted oral presentation abstracts that are not selected will be considered for a poster presentation.

ICCovid POSTER PRESENTATION

  • Accepted posters will be scheduled to display at the Congress on May 18-20, 2022 .
  • An author may present multiple posters as long as they are scheduled on different dates.
  • Poster format:
    • Layout: landscape
    • Maximum Dimensions:
      • Inches: 60 inches (wide) x 42 inches (high)
      • Meters: 1.52 meters (wide) x 1.07 meters (high)
        • We advise printing your poster slightly smaller than the dimensions above to allow room for the poster number. No audiovisual equipment is available for poster presentations. Push pins will be provided.

TOPICS

    •
  • Anti-Retroviral Therapy
    • •
  • Antiviral Drug Discovery and Development
    • •
  • Business & Drug Development for Coronaviruses
    • •
  • Bioinformatics and Computational Biology
    • •
  • Clinical and Diagnostic Virology
    • •
  • Clinical Trials of Drug Therapeutics
    • •
  • Clinical Trials of Vaccines
    • •
  • Coronavirus (COVID-19)-General Topics
    • •
  • Current Focus in Virology Research
    • •
  • Drug Discovery & Development
    • •
  • Emerging Viral Pandemics
    • •
  • Epidemiology of Covid-19
    • •
  • Genetics of Viral Evolution and Dynamics
    • •
  • Health Economics
    • •
  • Immune Response Viral Evasion Mechanisms
    • •
  • Investment Opportunities
    • •
  • Molecular and Cellular Virology
    • •
  • Neurologic Viral Diseases
    • •
  • Pediatric Viral Infectious Diseases
    • •
  • Public Policy
    • •
  • Respiratory Viral Diseases
    • •
  • Society Impact
    • •
  • Patient Care and Best Practice
    • •
  • Vaccine Discovery & Development
    • •
  • Viral Replication and Virus-Host Interactions
    • •
  • Virus Structure and Entry
    • •
  • Virus Transmission and Pathogenesis

ICCovid 2022 Confidentiality Agreement and Embargo Policy

All materials presented at the International Congress on Covid are embargoed for publication and broadcast until the officially scheduled date and time of presentation unless the Coronavirus Research International Society provides written notice of change of date and/or time in advance.